PUBLIC LAW 108–173—DEC. 8, 2003
117 STAT. 2173
(B) ensure that funding provided under the grant is expended only for the purposes for which it is made. (4) AUDIT.—The Secretary shall conduct appropriate audits of grants under this section. (5) MATCHING REQUIREMENT.—The applicant for a grant under this section shall agree, with respect to the costs to be incurred by the applicant in implementing an electronic prescription drug program, to make available (directly or through donations from public or private entities) non-Federal contributions toward such costs in an amount that is not less than 50 percent of such costs. Non-Federal contributions under the previous sentence may be in cash or in kind, fairly evaluated, including plant, equipment, or services. Amounts provided by the Federal Government, or services assisted or subsidized to any significant extent by the Federal Government, may not be included in determining the amount of such contributions. (d) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated to carry out this section $50,000,000 for fiscal year 2007 and such sums as may be necessary for each of fiscal years 2008 and 2009. SEC. 109. EXPANDING THE WORK OF MEDICARE QUALITY IMPROVEMENT ORGANIZATIONS TO INCLUDE PARTS C AND D.
(a) APPLICATION TO MEDICARE MANAGED CARE AND PRESCRIPTION DRUG COVERAGE.—Section 1154(a)(1) (42 U.S.C. 1320c–3(a)(1)) is amended by inserting ‘‘, to Medicare Advantage organizations pursuant to contracts under part C, and to prescription drug sponsors pursuant to contracts under part D’’ after ‘‘under section 1876’’. (b) PRESCRIPTION DRUG THERAPY QUALITY IMPROVEMENT.—Section 1154(a) (42 U.S.C. 1320c–3(a)) is amended by adding at the end the following new paragraph: ‘‘(17) The organization shall execute its responsibilities under subparagraphs (A) and (B) of paragraph (1) by offering to providers, practitioners, Medicare Advantage organizations offering Medicare Advantage plans under part C, and prescription drug sponsors offering prescription drug plans under part D quality improvement assistance pertaining to prescription drug therapy. For purposes of this part and title XVIII, the functions described in this paragraph shall be treated as a review function.’’. (c) EFFECTIVE DATE.—The amendments made by this section shall apply on and after January 1, 2004. (d) IOM STUDY OF QIOS.— (1) IN GENERAL.—The Secretary shall request the Institute of Medicine of the National Academy of Sciences to conduct an evaluation of the program under part B of title XI of the Social Security Act. The study shall include a review of the following: (A) An overview of the program under such part. (B) The duties of organizations with contracts with the Secretary under such part. (C) The extent to which quality improvement organizations improve the quality of care for medicare beneficiaries. (D) The extent to which other entities could perform such quality improvement functions as well as, or better than, quality improvement organizations.
VerDate 11-MAY-2000
13:59 Aug 30, 2004
Jkt 019194
PO 00000
Frm 00109
Fmt 6580
Sfmt 6581
42 USC 1320c–3 note. 42 USC 1320c note.
D:\STATUTES\2003\19194PT3.001
APPS10
PsN: 19194PT3
�
